PDSB
Price
$1.30
Change
+$0.05 (+4.00%)
Updated
Sep 3 closing price
Capitalization
60.16M
69 days until earnings call
VIVS
Price
$2.52
Change
+$0.18 (+7.69%)
Updated
Sep 3 closing price
Capitalization
6.53M
Interact to see
Advertisement

PDSB vs VIVS

Header iconPDSB vs VIVS Comparison
Open Charts PDSB vs VIVSBanner chart's image
PDS Biotechnology
Price$1.30
Change+$0.05 (+4.00%)
Volume$566.31K
Capitalization60.16M
VivoSim Lab
Price$2.52
Change+$0.18 (+7.69%)
Volume$1.24M
Capitalization6.53M
PDSB vs VIVS Comparison Chart in %
Loading...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDSB vs. VIVS commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Buy and VIVS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (PDSB: $1.30 vs. VIVS: $2.52)
Brand notoriety: PDSB and VIVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 112% vs. VIVS: 337%
Market capitalization -- PDSB: $60.16M vs. VIVS: $6.53M
PDSB [@Biotechnology] is valued at $60.16M. VIVS’s [@Biotechnology] market capitalization is $6.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 0 FA rating(s) are green whileVIVS’s FA Score has 1 green FA rating(s).

  • PDSB’s FA Score: 0 green, 5 red.
  • VIVS’s FA Score: 1 green, 4 red.
According to our system of comparison, VIVS is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 7 TA indicator(s) are bullish while VIVS’s TA Score has 6 bullish TA indicator(s).

  • PDSB’s TA Score: 7 bullish, 2 bearish.
  • VIVS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than VIVS.

Price Growth

PDSB (@Biotechnology) experienced а +1.56% price change this week, while VIVS (@Biotechnology) price change was +36.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

PDSB is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PDSB($60.2M) has a higher market cap than VIVS($6.53M). VIVS YTD gains are higher at: 408.806 vs. PDSB (-23.313). VIVS has higher annual earnings (EBITDA): -1.72M vs. PDSB (-32.36M). PDSB has more cash in the bank: 31.9M vs. VIVS (9.06M). VIVS has less debt than PDSB: VIVS (822K) vs PDSB (18.5M). VIVS has higher revenues than PDSB: VIVS (142K) vs PDSB (0).
PDSBVIVSPDSB / VIVS
Capitalization60.2M6.53M923%
EBITDA-32.36M-1.72M1,886%
Gain YTD-23.313408.806-6%
P/E RatioN/AN/A-
Revenue0142K-
Total Cash31.9M9.06M352%
Total Debt18.5M822K2,251%
FUNDAMENTALS RATINGS
PDSB vs VIVS: Fundamental Ratings
PDSB
VIVS
OUTLOOK RATING
1..100
2030
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
10092
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
6235
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VIVS's Valuation (19) in the Biotechnology industry is in the same range as PDSB (35) in the Pharmaceuticals Major industry. This means that VIVS’s stock grew similarly to PDSB’s over the last 12 months.

VIVS's Profit vs Risk Rating (92) in the Biotechnology industry is in the same range as PDSB (100) in the Pharmaceuticals Major industry. This means that VIVS’s stock grew similarly to PDSB’s over the last 12 months.

VIVS's SMR Rating (96) in the Biotechnology industry is in the same range as PDSB (99) in the Pharmaceuticals Major industry. This means that VIVS’s stock grew similarly to PDSB’s over the last 12 months.

VIVS's Price Growth Rating (35) in the Biotechnology industry is in the same range as PDSB (62) in the Pharmaceuticals Major industry. This means that VIVS’s stock grew similarly to PDSB’s over the last 12 months.

VIVS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PDSB (100) in the Pharmaceuticals Major industry. This means that VIVS’s stock grew similarly to PDSB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDSBVIVS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BON1.480.07
+4.96%
Bon Natural Life Limited
ENTX1.980.05
+2.59%
Entera Bio Ltd
JBHT144.25-0.74
-0.51%
J.B. Hunt Transport Services
FL24.15-0.55
-2.23%
Foot Locker
INNV3.69-0.14
-3.66%
InnovAge Holding Corp

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with IDYA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
+0.81%
IDYA - PDSB
44%
Loosely correlated
+3.79%
DYN - PDSB
44%
Loosely correlated
+0.07%
ARCT - PDSB
44%
Loosely correlated
-1.82%
RXRX - PDSB
43%
Loosely correlated
-0.85%
IMNM - PDSB
42%
Loosely correlated
-2.42%
More

VIVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with LVTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
-4.10%
LVTX - VIVS
42%
Loosely correlated
-0.64%
GLTO - VIVS
38%
Loosely correlated
-5.66%
RENB - VIVS
26%
Poorly correlated
-4.41%
KRRO - VIVS
26%
Poorly correlated
-3.79%
PDSB - VIVS
26%
Poorly correlated
+0.81%
More